November 09, 2026
Life Science Magazines About Us Contact Us
Life Science Newswire Service™ (LS)
Submit a Press Release
  • Analytical chemistry
  • Business
  • Biomanufacturing & bioprocessing
  • Biotechnology
  • Diagnostics
  • Drug development
  • More News
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • Press Releases
Reading: This week in Drug Discovery (19 – 23 January) 
Share
Font ResizerAa
Life Science Newswire Service™ (LS)Life Science Newswire Service™ (LS)
Search
  • Business
  • Press Releases
  • Life Science Magazines
  • Life Sciences
    • Analytical chemistry
    • Biomanufacturing & bioprocessing
    • Biotechnology
    • Diagnostics
    • Drug development
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • About Us
  • Contact Us
  • Submit a Press Release
LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
Life Science Newswire Service™ (LS) > Blog > Life Sciences > Drug development > This week in Drug Discovery (19 – 23 January) 
Drug development

This week in Drug Discovery (19 – 23 January) 

By Newsroom
Last updated: January 25, 2026
1 Min Read
Share


News round-up for 19 – 23 January by Bruno Quinney, Content Team at DDW. 

This week in DDW, innovative therapies have shown encouraging results in tackling melanoma and concussion. Elsewhere, a UK-Canadian partnership looks to advance vaccine technology. 

The top stories: 

 

Combination therapy could slash melanoma mortality risk 

An investigational mRNA-based individualised neoantigen therapy (INT) reduced the risk of high-risk melanoma recurrence or death by 49% when combined…



Source link

TAGGED:CanadaCell and gene therapyClinical trialConcussionELRIGEuropean Medicines AgencyMelanomaMerckModernaOxeia BiopharmaceuticalsregulatoryUKVaccines
Share This Article
Facebook Email Copy Link Print

HOT NEWS

New York’s Climate Change Superfund Act

Environmental Science
April 5, 2025

CAT ET3 Software French Language Support & How to Change Language – OBDII.SHOP OFFICIAL BLOG

Does CAT Caterpillar ET3 diagnostic software support French? Yes! CAT Electronic Technician (CAT ET) supports…

November 9, 2026

Therapeutic Electrodes Market Projected to Grow at a CAGR of 6.2% During the Forecast Period 2021-2026

  Therapeutic Electrodes Market (I-BusinessNews.Com, August 04, 2021 ) The Therapeutic Electrodes Market size was…

August 4, 2021

Breast Imaging Market to reach USD 5.4 billion by 2025, at a CAGR of 8.1%

(I-BusinessNews.Com, August 05, 2021 ) The breast imaging market is projected to grow from an…

August 5, 2021

YOU MAY ALSO LIKE

How Press Release Distribution Enhances the Process of Drug Development

The drug development process is a complex and lengthy endeavor that involves research, clinical trials, regulatory approvals, and commercialization. Given…

Drug development
April 9, 2025

The Future of Model-Informed Drug Development (MIDD)

This publication provides a forward-looking overview of the evolution and expanding role of Model-Informed Drug Development (MIDD) across modern drug…

Drug development
August 31, 2026

Novartis and BMS pause CAR-T trials due to safety concerns

Novartis and Bristol Myers Squibb (BMS) have both paused clinical trials of CAR-T cell therapies for lupus and other autoimmune…

Drug development
September 7, 2026

Before its recent Phase 3 LSD win, Definium modeled up to $70,000 a year for a therapy that could fill a clinical shift

Definium framed DT120’s potential value at $2.8 billion to $7 billion for every 100,000 patients treated, based on assumed annual…

Drug development
August 24, 2026
Life Science Newswire Service™ (LS)

Contact Us

  • Whatsapp: +1 832-716-2363
  • Skype: Groupwebmedia
  • Telegram: Groupwebmedia

Share Us

About Us

Life Science Newswire Services (LS)™ aggregates, publishes and distributed news about the Life Science industry. In association with EmailWire, LS provides press release distribution services in the Life Science sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us.

Categories

Analytical chemistry
Business
Biomanufacturing & bioprocessing
Biotechnology
Diagnostics
Drug development
Environmental Science
Food & beverage
Forensic science
Healthcare
Hospitals
Lab tools
Materials science
Microbiology
Nanotechnology
Pharma & Biopharma
Pharmacy
Veterinary
Water Management
Life Science Magazines
Press Releases

Recent News

CAT ET3 Software French Language Support & How to Change Language – OBDII.SHOP OFFICIAL BLOG
November 9, 2026
Competition Bureau updates greenwashing guidelines
November 9, 2026
Beer demand pours on despite pressures
November 9, 2026
Pennsylvania revokes hospital’s license, orders closure
November 8, 2026

Life Science Magazines

A New Blueprint: Innovations in DNA Synthesis
July 7, 2026
Inside HCP Decision-Making – The 2026 Access Landscape
July 6, 2026
Checklist for Submitting to an Institutional Review Board
July 2, 2026
Unlocking the Power of Primary Care in Cronic Disease Research
July 2, 2026

LS Newswire Service™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?